¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Chronic parametritis and pelvic cellulitis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • renal pelvic tumor
    ½Å¿ìÁ¾¾ç
  • renal pelvic tumor
    ½Å¿ìÁ¾¾ç(ãìéâðþåË)
  • superior fascia of pelvic diaphragm
    À§°ñ¹Ý°¡·Î¸·±Ù¸·
  • superior pelvic strait
    °ñ¹ÝÀÔ±¸(¡­ìýÏ¢).
  • tendinous arch of pelvic fascia
    °ñ¹Ý±Ù¸·ÈûÁÙȰ
  • total pelvic exenteration
    °ñ¹ÝÀüÀûÃâ¼ú
  • transverse diameter of pelvic inlet
    ³»°ñ¹ÝȾ°æ,°ñ¹ÝÀÔ±¸È¾°æ(ÍéÚïìýÏ¢üôÌÓ).
  • transverse diameter of pelvic inlet
    °ñ¹Ý»ó
  • transverse diameter of pelvic outlet
    ¿Ü°ñ¹ÝȾ°æ,°ñ¹ÝÃⱸ(¡­õóÏ¢)Ⱦ°æ.
  • transverse diameter of pelvic outlet
    °ñ¹ÝÃâ?¡­õóÏ¢)Ⱦ°æ.
  • visceral pelvic fascia
    ³»ÀåÂʰñ¹Ý±Ù¸·
  • alcoholism, chronic
    ¾ËÄÚ¿Ã Áßµ¶, ¸¸¼º(¡­ñéÔ¸)
  • brain syndrome, acute, chronic
    ±Þ¼º, ¸¸¼º ³úÁõÈıº.
  • bronchitis, chronic
    ±â°üÁö¿°(¡­æú), ¸¸¼º(Ø·àõ)
  • carrier, chronic
    ¸¸¼ºº¸±ÕÀÚ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 9
CIDP chronic idiopathic polyradiculopathy; chronic inflammatory demyelinating polyradiculoneuropathy
CIP chronic idiopathic polyradiculoneuropathy; chronic intestinal pseudo-obstruction; Collection de l'In...
CLD chloride diarrhea; chronic liver disease; chronic lung disease; congenital limb deficiency; crystal ...
CLL cholesterol-lowering lipid; chronic lymphatic leukemia; chronic lymphocytic leukemia; cow lung lavag...
CML carboxymethyl lysine; cell-mediated lymphocytotoxicity; cell-mediated lympholysis; central motor lat...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 9
CGD chronic granulomatous disese
CHF Chronic Heart Failure
CH Chronic Hepatitis
cHC Chronic Hepatitis C
CIU Chronic Idiopathic Urticaria
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • chronic exposure
    ¸¸¼º ³ëÃâ
  • chronic factitious disorder with physical symptom
    ¸¸¼º ÀΰøÀû Àå¾Ö ½ÅüÀû
  • chronic fatigue syndrome
    ¸¸¼º ÇÇ·Î ÁõÈıº
    ½±°Ô ÇǰïÇϰí ÁöÄ¡¸ç ¸öÀÌ ³ª¸¥ÇØÁö´Â µîÀÇ ÇÇ·Î Áõ¼¼°¡ 6°³¿ù ÀÌ»ó ¸¸¼ºÀûÀ¸·Î Áö¼ÓÇÏ´Â Áõ»ó. È®½ÇÇÑ ¿øÀÎÀº ¹àÇôÁ® ÀÖÁö ¾Ê°í, ¹ÙÀÌ·¯½º °¨¿°ÀÌ ±× ¿øÀÎÀÇ Çϳª·Î ÃßÁ¤µÈ´Ù. Æò¼Ò °Ç°­ÇÑ »ç¶÷¿¡°Ô¼­ °¨±â³ª ¸ö»ì ±â¿îÀÌ ÀÖ´Ù°¡ ÀÌ·± ÇǷΰ¡ ³ªÅ¸³­´Ù. ´ëü·Î Ưº°ÇÑ Ä¡·á°¡ ÇÊ¿ä¾øÀÌ ÀúÀý·Î Ä¡À¯µÇ³ª ÇǷθ¦ ´À³¢°Ô ÇÏ´Â ´Ù¸¥ Áúº´ÀÇ À¯¹«¸¦ È®ÀÎÇÏ´Â °ÍÀÌ Áß¿äÇÏ´Ù. ƯÈ÷ ½ºÆ®·¹½º, ¿ì¿ïÁõ, ºÒ¾ÈÀå¾Ö µî°ú °°Àº Á¤½ÅÀû ¹®Á¦°¡ ¾à 50 %¸¦ Â÷ÁöÇϸç, ½ÅüÀû ÁúȯÀ¸·Î´Â ´ç´¢º´, °©»ó¼± Áúȯ, ¸¸¼º È£Èí±â Áúȯ, ºóÇ÷, °áÇÙ, °£¿°, ½ÅÀå ÁúȯÀ̳ª ¾Ï µî¿¡ ÀÇÇØ¼­µµ ¸¸¼ºÀû ÇǷΰ¨À» ´À³¥ ¼ö ÀÖ´Ù. ÀÌ¿Í °°Àº ÁúȯÀÌ ¾ø´Â °ÍÀÌ ÆÇ¸íµÇ¸é ¸¸¼º ÇÇ·Î ÁõÈıºÀ¸·Î Áø´ÜÇÒ ¼ö ÀÖ´Ù.
  • chronic flying sickness
    ¸¸¼º Ç×°øº´
    Àå±â°£ Ç×°ø±â¿¡ ž½ÂÇÏ´Â »ç¶÷¿¡°Ô ÀϾ´Â Á÷¾÷º´. Ç×°ø±âÀÇ ²÷ÀÓ¾ø´Â µ¿¿ä, ¼±È¸, °¡¼Óµµ, °í°ø ºñÇàÀ¸·ÎºÎÅÍ ¿À´Â »ê¼ÒÀÇ ºÎÁ·, ±â¾ÐÀÌ ³·Àº °í°øÀ» ºñÇàÇϰųª Àú¾Ð½Ç¿¡¼­ ÀÛ¾÷À» ÇÏ´Â °æ¿ì, ±×°ÍÀ¸·Î ±Þ¼º ÁúȯÀÌ ÀϾÁö ¾Ê´Â Á¤µµÀÇ È¯°æÀÌ Àå±â°£¿¡ °ÉÃļ­ µÇÇ®ÀÌµÉ ¶§ ¹ß»ýÇϱ⠽±´Ù. Áõ¼¼´Â Ãʱ⿡ ´«ÀÇ ÇÇ·Î, µÎÅë, ÇǷΰ¨ µîÀÇ ÀÚ°¢ Áõ¼¼°¡ ÀϾ°í, ÀÌ¿Í °°Àº ´Ü°è°¡ Áö³ª¸é ÃÊÁ¶°¨, ½Å°æÁú, ºÒ¸éÁõ, ±â¾ï·Â, ÁýÁß·ÂÀÇ °¨Åð¿Í ÇÔ²² ±¸Åä, Çö±âÁõ, ¼ÒÈ­ºÒ·® µîÀÌ ÀϾ´Ù. À̰ÍÀº °í°ø ºñÇàÀ̳ª, ¼Óµµ°¡ ºü¸£°í ¼±È¸°¡ ½ÉÇÑ ÀüÅõ±â¸¦ Á¶Á¾ÇÏ´Â ÀüÅõ Á¶Á¾»ç¿¡°Ô ¹ß»ýµÇ´Â °æ¿ì°¡ ¸¹´Ù.
  • chronic gingivitis
    ¸¸¼º Ä¡Àº¿°
    1. º¯¿¬ Ä¡ÀºÀÇ ºÎÁ¾, ÃâÇ÷À» º¸ÀδÙ. È­³ó¼ºÀ̸ç, Ä¡ÀºÀÇ Á¡¸ôÀÌ ¼Ò½ÇµÈ´Ù. ±¹¼ÒÀûÀÌ ¿äÀÎÀ¸·Î´Â ¹Ì»ý¹°, À½½Ä¹° ¾ÐÀÔ, ºÎÀûÀýÇÑ º¸Á¸ óġ³ª º¸Ã¶¹°, ±¸È£Èí, Ä¡¾ÆÀÇ À§Ä¡ ÀÌ»ó, È­Çй°Áú ȤÀº ¾à¹° º¹¿ëÀÌ ÀÖÀ¸¸ç, Àü½ÅÀûÀÎ ¿äÀÎÀ¸·Î´Â ¿µ¾ç Àå¾Ö, ¾à¸® ÀÛ¿ë, ÀÓ½Å, ´ç´¢, ¾Ë·¯Áö, À¯Àü, Á¤½Å Áúȯ µîÀÌ ÀÖ´Ù. 2. Ä¡ÀºÀÌ Àü¹ÝÀûÀ¸·Î â¹éÇÏ°í ¼¶À¯¼º ¿Ü°üÀ» °¡Áö´Â ¿­±¸ ¸é°ú Ä¡°£ À¯µÎÀÇ ¿°ÁõÀÌ´Ù. Ä¡Àº À¯µÎÀÇ ¼Ò½Ç°ú °°Àº Ä¡ÀºÀÇ ¿ÜÇü º¯È­µµ ÀϾ ¼ö ÀÖ´Ù. À̰ÍÀº ¼ö³â°£ÀÇ ¿°Áõ¼º Ä¡Àº ¼Õ»ó¿¡ ´ëÇÑ ¸¸¼ºÀû ¼øÈ¯Àû º¹±¸ ¹ÝÀÀÀ̸ç Ä¡ÁÖ¿°ÀÇ Æ¯Â¡°ú ¿¬°üµÉ ¶§°¡ ÀÖ´Ù.
  • chronic granulocytic leukemia
    ¸¸¼º °ú¸³±¸ ¹éÇ÷º´, ¸¸¼º °ú¸³±¸¼º ¹éÇ÷º´
  • chronic headache
    ¸¸¼º µÎÅë
  • chronic hemorrhage
    ¸¸¼º ÃâÇ÷
  • chronic hepatitis B
    ¸¸¼º BÇü °£¿°
  • chronic hyperplastic gingivitis
    ¸¸¼º Áõ½Ä¼º Ä¡Àº¿°
  • chronic hypertrophic pharyngitis
    ¸¸¼º ºñÈÄ Àεο°, ¸¸¼º ºñÈļº Àεο°
  • chronic hypochromic anemia
    ¸¸¼º Àú»ö¼Ò¼º ºóÇ÷
  • chronic idiopathic megacolon
    ¸¸¼º Ư¹ß¼º °Å´ë °áÀå, ¸¸¼º Ư¹ß¼º °Å´ë °áÀåÁõ
  • chronic infantile neurological cutaneous articular syndrome
    ¸¸¼º À¯¾Æ ½Å°æ ÇǺαº
  • chronic inflammation
    ¸¸¼º ¿°Áõ
    ÀϹÝÀûÀ¸·Î ¼öÁÖ³ª ¼ö°³¿ùµ¿¾È Àå±â°£ Áö¼ÓµÇ¸ç ¿°Áõ ºÎÀ§¿¡¼­ ¿°Áõ ¹ÝÀÀ, Á¶Á÷ÀÇ ÆÄ±«, Ä¡À¯ °úÁ¤ÀÌ µ¿½Ã¿¡ °üÂûµÇ°í ÀÖ´Â ¿°Áõ ¹ÝÀÀ. ¼­¼­È÷ ÀϾ´Â °æ¿ì°¡ ´ëºÎºÐÀÌ°í ¿©·¯ °¡Áö ¿øÀο¡ ÀÇÇØ ¹ß»ýÇÒ ¼ö ÀÖÀ¸³ª ÁÖ·Î °¨¿° »óŰ¡ Áö¼ÓµÇ´Â °æ¿ì, Áö¼ÓÀûÀÎ µ¶¼º ¹°Áú¿¡ ³ëÃâ, ÀÚ°¡ ¸é¿ª¿¡ ÀÇÇÑ ¿°Áõ Áß ¾î´À ÇÑ °úÁ¤À» ÅëÇØ ¹ß»ýÇÑ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
chronic granulomatous disease <disease> Chronic granulomatous disease is usually fatal in childhood, in which the production of hydrogen peroxide by phagocytes does not occur because of a lesion in an NADP dependent oxidase.
Catalase negative bacteria are not killed and there is no luminol enhanced chemiluminescence when the cells are tested. The absence of the oxygen dependent killing mechanism is not itself fatal but seriously compromises the primary defense system.
at least three separate lesions can cause the syndrome, the commonest being a defect in plasma membrane cytochrome.
Acronym: CGD
(12 Jan 1998)
chronic granulomatous disease of childhood <radiology> Disorder of phagocytosis, two forms: X-linked recessive, autosomal recessive, usually fatal in childhood, infection by nonpathogenic organisms (catalase positive), pneumonia, osteomyelitis, diarrhoea, abdominal pain Findings: recurrent pneumonia (resolves incompletely, with abscess formation), adenopathy (big hila), hepatosplenomegaly, calcified granulomata in liver, spleen, lymph nodes, gastric antral narrowing (!) Cf: Chediak-Higashi syndrome More info: chronic granulomatous disease
(12 Dec 1998)
chronic haemorrhagic villous synovitis <radiology> Monoarthritis, young adults, erosions on BOTH sides of joint (!), probably inflammatory, haemosiderin deposited in synovium, articular cartilage preserved (despite extensive marginal erosions; similar to gout), NO calcification Differential diagnosis: TB (associated atrophy of muscle and bone), rheumatoid arthritis (symmetrical), synovial sarcoma (with or without calcified; outside joint), synovial osteochondromatosis
(12 Dec 1998)
chronic hepatitis Any of several types of hepatitis persisting for more than six months, often progressing to cirrhosis.
Synonym: chronic active liver disease.
(05 Mar 2000)
chronic hypertensive disease The chronic accumulative effects of long-standing high blood pressure on such vital organs as the heart, kidney, and brain.
(05 Mar 2000)
chronic hypertrophic vulvitis Swelling of the vulval tissues due to lymphatic obstruction; in some cases it may be caused by filariasis, with induration or ulceration of the skin.
Synonym: elephantiasis vulvae.
(05 Mar 2000)
chronic hyperventilation syndrome <syndrome> Reduced CO2 content of the blood (hypocapnia) as a result of hyperventilation of prolonged duration; may occur in anxiety states and in some chronic organic, usually cardiovascular, disease; alkalaemia, paresthesia, and tetany may occur.
(05 Mar 2000)
chronic idiopathic jaundice <syndrome> An inherited disorder (autosomal recessive) that is characterised by long-standing mild jaundice. This occurs secondary to an abnormality in the transport of bilirubin from the liver to the biliary system. This leads to an accumulation of bilirubin in the liver. Avoidance of alcohol and medications which can affect the liver is important.
Inheritance: autosomal recessive.
(27 Sep 1997)
chronic idiopathic xanthomatosis Vague or indefinite term for inherited abnormalities of lipid metabolism leading to xanthoma formation (e.g., primary familial xanthomatosis).
(05 Mar 2000)
chronic illness An illness that has persisted for a long period of time. It is a continuing disease process.
(12 Dec 1998)
chronic inflammation An inflammation that may begin with a relatively rapid onset or in a slow, insidious, and even unnoticed manner, tends to persist for several weeks, months, or years and has a vague and indefinite termination; results when the injuring agent (or products resulting from its presence) persists in the lesion, and the host's tissues respond in a manner (or to a degree) that is not sufficient to overcome completely the continuing effects of the injuring agent.
(05 Mar 2000)
chronic inflammatory demyelinating polyneuropathy An uncommon, acquired, demyelinating sensorimotor polyneuropathy, clinically characterised by insidious onset, and slow evolution, (either steady progression or stepwise), and chronic course; symmetrical weakness is a predominant symptom, often involving proximal leg muscles, accompanied by paresthesias, but not pain; CSF examination shows elevated protein, while electrodiagnostic studies reveal evidence of a demyelinating process, primarily conduction slowing rather than block; sometimes responds to prednisone.
(05 Mar 2000)
chronic inflammatory polyneuropathy <neurology, pathology> A disorder that involves the slow progressive (or recurrent) inflammation of multiple nerves. Loss of movement and sensation are common findings. The exact cause is related to an abnormal immune response.
The acute form of this illness is known as Guillain-Barre syndrome. Treatment often includes systemic corticosteroids or chemotherapeutic agents to suppress the immune system. Prognosis is variable.
Origin: Gr. Pathos = disease
(27 Sep 1997)
chronic interstitial hepatitis An obsolete term for cirrhosis of the liver.
(05 Mar 2000)
chronic interstitial hypertrophic neuropathy dejerine-Sottas disease
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 9
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 9
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 9
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 9
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 9
ÅëÇÕ°Ë»ö ¿Ï·á